RxDoctor Payments DataLook up a doctor →

Michael Dever

Internal Medicine · Windermere, FLNPI 1588717862

Payments from drug & device makers

$23,959,261in general payments, 2019–2025

Across 1,771 payments — averaging $13,529 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$16.3M
  • Janssen Research & Development, LLC$4.3M
  • Romark Laboratories, LC$953K
  • GSK$533K
  • Alnylam Pharmaceuticals Inc.$499K
  • Regeneron$337K
  • plus $1M from 18 others
$15,159in research payments, 2019–2025

Across 9 payments — averaging $1684.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$10K
  • Eli Lilly$3K
  • Bausch Health US, LLC$2K

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$23,959,261 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Windermere

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →